- GBI & PARTNERS
- Innovent recruits Sanofi’s global head of research as group president
Innovent recruits Sanofi’s global head of research as group president
Suzhou-based Innovent Biologics Inc., (HKEX.01801) announced the appointment of a group president to head global R&D, portfolio strategy, business development, and international operations. Dr. Liu Yong Jun is the appointee, and will report to Innovent’s founder and CEO Dr. Michael Yu.
Dr. Yong has a prestigious research background in immunology, oncology, and translational medicine. Early industry roles included senior scientist positions at Schering-Plough from 1991, while he began an academic career in 2002, serving as chairman of the immunology department and founder of the Center for Cancer Immunology Research at the University of Texas, MD Anderson Cancer Center. In 2011 Dr. Liu joined the Baylor Immunology Research Institute, and finally rejoined industry with AstraZeneca subsidiary Medimmune as Chief Scientific Officer (CSO) from 2014. Prior to joining Innovent, Dr. Liu served as global head of research at Sanofi from 2016 to 2020.